News Image

Citius Oncology Expands Distribution Network for LYMPHIR with Execution of Distribution Services Agreement with Cencora

Provided By PR Newswire

Last update: Jul 15, 2025

Agreement with global pharmaceutical solutions provider enhances commercial infrastructure and reinforces launch readiness for FDA-approved immunotherapy LYMPHIRâ„¢

Read more at prnewswire.com

CITIUS PHARMACEUTICALS INC

NASDAQ:CTXR (9/12/2025, 8:00:01 PM)

After market: 1.2099 0 (-0.01%)

1.21

+0.01 (+0.83%)


CITIUS ONCOLOGY INC

NASDAQ:CTOR (9/12/2025, 8:00:01 PM)

After market: 1.9 -0.01 (-0.52%)

1.91

+0.02 (+1.06%)



Find more stocks in the Stock Screener

Follow ChartMill for more